British study shows Clinuvel drug effective on DNA of UV-damaged skin
Clinuvel Pharmaceuticals Ltd (ASX:CUV) has announced positive final results from a British-conducted…
Clinuvel Pharmaceuticals Limited (ASX:CUV)
About Clinuvel Pharmaceuticals Limited
Key Information
CUV In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 17/10/2024 | Final Director's Interest Notice - Brenda Shanahan | 240.12KB | 436 |
| 16/10/2024 | Results of Meeting | 88.49KB | 2.8K |
| 16/10/2024 | Price Sensitive PS Managing Director Presentation | 1.33MB | 938 |
| 16/10/2024 | Chair's Address | 117.74KB | 5.1K |
| 03/10/2024 | Appendix 3Y - Karen Agersborg | 272.56KB | 1.3K |
| 02/10/2024 | Notification of cessation of securities - CUV | 13.5KB | 374 |
| 01/10/2024 | Price Sensitive PS Canadian New Drug Submission for SCENESSE in EPP filed | 78.42KB | 6.4K |
| 27/09/2024 | Update - Notification of buy-back - CUV | 15.7KB | 3.6K |